Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
CVR number: 32323502
Tuborg Boulevard 12, 2900 Hellerup
Income statement (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Costs of manufacturing | -30.40 | ||||
| Gross profit | -1.85 | -30.40 | -6.05 | -8 328.99 | -44 610.52 |
| Costs of management | - 118.78 | -95.31 | -88.04 | -89.54 | -8.75 |
| EBIT | - 120.63 | - 125.71 | -94.08 | -8 418.53 | -44 619.27 |
| Other financial income | 351.28 | 358.57 | 365.05 | 320.75 | 202.42 |
| Other financial expenses | -0.28 | -0.37 | -0.08 | -0.35 | - 135.80 |
| Pre-tax profit | 230.37 | 232.49 | 270.89 | -8 098.13 | -44 552.65 |
| Income taxes | -19.95 | -35.52 | -57.87 | 8.41 | 61.55 |
| Net earnings | 210.42 | 196.96 | 213.02 | -8 089.72 | -44 491.10 |
Assets (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 14 400.28 | 14 583.44 | 14 798.86 | ||
| Prepayments and accrued income | 1 059.76 | ||||
| Current other receivables | 6.04 | 6.59 | 5.66 | 5 661.99 | |
| Short term receivables total | 14 406.32 | 14 590.04 | 14 804.52 | 6 721.75 | |
| Cash and bank deposits | 5.62 | 21.65 | 17.06 | 11.63 | 7.64 |
| Cash and cash equivalents | 5.62 | 21.65 | 17.06 | 11.63 | 7.64 |
| Balance sheet total (assets) | 14 411.94 | 14 611.69 | 14 821.58 | 6 733.38 | 7.64 |
Equity and liabilities (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 134.04 | 134.04 | 134.04 | 134.04 | 134.04 |
| Shares repurchased | -8 089.72 | -44 491.10 | |||
| Other reserves | 8 089.72 | 44 491.10 | |||
| Retained earnings | 14 059.78 | 14 270.20 | 14 467.17 | 14 680.18 | 6 590.46 |
| Profit of the financial year | 210.42 | 196.96 | 213.02 | -8 089.72 | -44 491.10 |
| Shareholders equity total | 14 404.25 | 14 601.21 | 14 814.23 | 6 724.51 | -37 766.60 |
| Non-current owed to group member | 37 763.82 | ||||
| Non-current liabilities total | 37 763.82 | ||||
| Short-term deferred tax liabilities | 8.88 | 10.41 | |||
| Other non-interest bearing current liabilities | 7.70 | 10.48 | 7.36 | ||
| Current liabilities total | 7.70 | 10.48 | 7.36 | 8.88 | 10.41 |
| Balance sheet total (liabilities) | 14 411.94 | 14 611.69 | 14 821.58 | 6 733.38 | 7.64 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.